Charles Schwab Investment Management Inc. Buys 38,749 Shares of Avidity Biosciences, Inc. (NASDAQ:RNA)
Charles Schwab Investment Management Inc. grew its stake in shares of Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) by 3.9% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 1,028,931 shares of the biotechnology company’s stock after acquiring an additional 38,749 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in Avidity […]
